Fortress Biotech
Price & Volume
Stats
See more52W Range | $1.45-$4.53 |
Market Cap | $75.6M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $63.2M |
Revenue Growth (YoY) | 6.3% |
Gross Profit (12 Mos) | $30.4M |
Diluted EPS | -$0.07 |
News
See moreYahoo Finance • 27 days ago
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
Yahoo Finance • 2 months ago
Fortress Biotech’s Cyprium enters agreement to sell PRV for $205M
Yahoo Finance • 4 months ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
Yahoo Finance • 5 months ago
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
About
CEO | Dr. Lindsay Allan Rosenwald M.D. |
CFO | Mr. David Jin |
Address | 1111 Kane Concourse, Bay Harbor Islands, FL, United States, 33154 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 78 |
